Relation between Obesity and Anti-Mullerian Hormone

Effect of Weight Loss Diet on Anti-Mullerian Hormone Levels in Obese Women with Polycystic Ovary Syndrome (PCOS) A pilot study - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071529

Enrollment

Registered

2024-07-30

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium

Interventions

Intervention1: DIETARY: Effect will be seen before and after intervention NOT APPLICABLE - COMPARATOR AGENT Intervention2: Dietary: Effect will be seen before and after intervention Intervention3: Die

Eligibility

Inclusion criteria

Inclusion criteria: premenopausal nonpregnant nonlactating overweight and obese women Diagnosed with polycystic ovary syndrome

Exclusion criteria

Exclusion criteria: Women older than 40 years old Women who went through bariatric surgery Women under IVF In whom IVF is the only recommended treatment Lean PCOS patients

Design outcomes

Primary

Measure	Time frame
Outcome MeasureMeasure DescriptionTime Frame - At the beginning Anti- Mullerian hormone (AMH) levels Timepoint: 12 weeks	—

Secondary

Measure	Time frame
Weight loss change in BMI Impact of Weight on Quality of Life ?Lite Impact of Weight on Self Perceptions (IW-SP) Timepoint: Day-0, and Day 90 Day 0, and Day 90 Day 0, and Day 90 Day 0, and Day 90	—

Countries

India

Contacts

Public ContactDivya N Pai

KS Hegde Medical Academy

kshitiz.22uml069@student.nitte.edu.in8970930932

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026